December 11 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its CEO Ognyan Donev has acquired 2,164 shares in the company at a weighted average price of 3.4338 levs ($1.94/1.75 euro) per share.
Donev acquired the shares in three transactions on the Bulgarian Stock Exchange on December 10, Sopharma said in a bourse filing.
The shares represent a 0.0016% stake in Sopharma.
On Tuesday, Donev bought 8,511 shares in Sopharma at a weighted average price per share of 3.425 levs, representing a 0.006% stake.
At the end of September, Donev held a stake of below 5% in Sopharma directly, according to the company's most recent interim financial statement.
Indirectly, Donev is the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.
As at 12:15 CET on Wednesday, Sopharma's shares traded 0.29% higher at 3.45 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)